Search

Your search keyword '"Jeyakumar, Alwin"' showing total 13 results
Start Over Author "Jeyakumar, Alwin"
13 results on '"Jeyakumar, Alwin"'

3. Eastern Canadian Gastrointestinal Cancer Consensus Conference 2019

Author

Gotfrit, Joanna, primary, Goodwin, Rachel, additional, Asmis, Timothy, additional, Hyde, Angela J., additional, Alcindor, Thierry, additional, Aubin, Francine, additional, Berry, Scott, additional, Bossé, Dominick, additional, Brown, Colin, additional, Burkes, Ronald, additional, Burnell, Margot, additional, Colwell, Bruce, additional, Corbett, Jessica, additional, Craswell, Jeff, additional, Daaboul, Nathalie, additional, Doherty, Mark, additional, Fleming, D. A. Barry, additional, Galvis, Luisa, additional, Goel, Rakesh, additional, Harb, Mohammed, additional, Jeyakumar, Alwin, additional, Jonker, Derek, additional, Kennedy, Erin, additional, Lock, Michael, additional, Mahmud, Aamer, additional, McCrea, Patrick H., additional, Nair, Vimoj, additional, Nassabein, Rami, additional, Nessim, Carolyn, additional, Ramjeesingh, Ravi, additional, Raza, Muhammad, additional, Saliba, Wissam, additional, Samimi, Satareh, additional, Singh, Simron, additional, Snow, Stephanie, additional, Tehfé, Mustapha, additional, Thirlwell, Michael, additional, Valdes, Mario, additional, Welch, Stephen, additional, and Vickers, Michael, additional

Published
2021
Full Text
View/download PDF

6. Review of nasopharyngeal carcinoma

Author

Jeyakumar, Anita, Brickman, Todd M., Jeyakumar, Alwin, and Doerr, Timothy

Subjects
Nasopharyngeal cancer -- History
Abstract

We review the literature on nasopharyngeal carcinoma that has been published within the past 5 years. Nasopharyngeal carcinoma is a highly morbid disease, and survival is poor. Its management remains [...]

Published
2006

8. Barriers to accessing healthcare services: A multidisciplinary approach towards improving pancreatic cancer survival in a Canadian province.

Author

Faour, Elizabeth, primary, Colwell, Bruce, additional, Lamond, Nathan William Dana, additional, Snow, Stephanie Leann, additional, Jeyakumar, Alwin S., additional, Patil, Nikhilesh Gajanan, additional, Costa, Andreu F., additional, Walsh, Mark, additional, Gala-Lopez, Boris, additional, Livingstone, Scott M, additional, Peltekian, Kevork, additional, Stueck, Ashley, additional, Huang, Weei-Yuarn, additional, Arnason, Thomas, additional, and Ramjeesingh, Ravi, additional

Published
2019
Full Text
View/download PDF

10. The clinical utility of baseline cardiac assessments prior to adjuvant anthracycline chemotherapy in breast cancer: a systematic review and meta-analysis.

Author

O'Brien, Pierre, Matheson, Kara, Jeyakumar, Alwin, Anderson, Kim, and Younis, Tallal

Abstract

Background: Cardiac assessment with multi-gated acquisition scan (MUGA) or echocardiography (ECHO) is commonly employed prior to adjuvant anthracycline-based chemotherapy (AA). However, the clinical utility of routine baseline cardiac assessments prior to AA for early-stage breast cancer (EBC) is unknown.Objectives: To determine: (i) the clinical utility of routine baseline cardiac assessments prior to AA for EBC and (ii) identify patients in whom baseline cardiac assessments may not be warranted.Methods: A systematic review of the literature was conducted to identify all relevant studies that met predefined criteria. The clinical utility was defined by: (i) the rates of abnormal baseline left ventricular ejection fraction (LVEF) and (ii) the rates of change in chemotherapy decisions prompted by baseline LVEF results.Results: Eight studies met our criteria, of whom six (n = 2545) reported rates of abnormal LVEF and six (n = 1713) reported rates of change in chemotherapy decision. Overall, 2.5% (95% CI 2.0-4.0%) of patients had abnormal baseline LVEF and 1.6% (95% CI 1.0-3.0%) had a change in chemotherapy decision. In subset analyses, the underlying imaging modality (ECHO vs. MUGA) or inclusion of patients with metastatic disease (YES vs. NO) did not significantly affect these rates. There were no consistently identified underlying predictors of abnormal baseline LVEF across studies.Conclusions: Routine baseline cardiac assessments prior to AA in all EBC patients have low yield and infrequently affect clinical management. Future studies should further examine potential predictors of abnormal cardiac functions in an attempt to identify low risk patients in whom routine baseline LVEF assessment may not be warranted and prevent delay in chemotherapy administration. [ABSTRACT FROM AUTHOR]

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results